STAT5 has recently been reported to oppose a network of transcription factors such as NF-κB and IKAROS in B cell acute lymphoblastic leukemia (52) and to interact with EZH2 (35). The gene discussed is STAT5A; the disease is B-cell acute lymphoblastic leukemia.